448 related articles for article (PubMed ID: 29669839)
1. A GXXXA Motif in the Transmembrane Domain of the Ebola Virus Glycoprotein Is Required for Tetherin Antagonism.
González-Hernández M; Hoffmann M; Brinkmann C; Nehls J; Winkler M; Schindler M; Pöhlmann S
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669839
[TBL] [Abstract][Full Text] [Related]
2. The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies.
Brinkmann C; Nehlmeier I; Walendy-Gnirß K; Nehls J; González Hernández M; Hoffmann M; Qiu X; Takada A; Schindler M; Pöhlmann S
J Virol; 2016 Dec; 90(24):11075-11086. PubMed ID: 27707924
[TBL] [Abstract][Full Text] [Related]
3. Tetherin Inhibits Nipah Virus but Not Ebola Virus Replication in Fruit Bat Cells.
Hoffmann M; Nehlmeier I; Brinkmann C; Krähling V; Behner L; Moldenhauer AS; Krüger N; Nehls J; Schindler M; Hoenen T; Maisner A; Becker S; Pöhlmann S
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429347
[TBL] [Abstract][Full Text] [Related]
4. Analysis of determinants in filovirus glycoproteins required for tetherin antagonism.
Gnirß K; Fiedler M; Krämer-Kühl A; Bolduan S; Mittler E; Becker S; Schindler M; Pöhlmann S
Viruses; 2014 Apr; 6(4):1654-71. PubMed ID: 24721789
[TBL] [Abstract][Full Text] [Related]
5. The Ebola virus glycoprotein and HIV-1 Vpu employ different strategies to counteract the antiviral factor tetherin.
Kühl A; Banning C; Marzi A; Votteler J; Steffen I; Bertram S; Glowacka I; Konrad A; Stürzl M; Guo JT; Schubert U; Feldmann H; Behrens G; Schindler M; Pöhlmann S
J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S850-60. PubMed ID: 21987761
[TBL] [Abstract][Full Text] [Related]
6. Ebola Virus Glycoprotein Promotes Enhanced Viral Egress by Preventing Ebola VP40 From Associating With the Host Restriction Factor BST2/Tetherin.
Gustin JK; Bai Y; Moses AV; Douglas JL
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S181-90. PubMed ID: 25821226
[TBL] [Abstract][Full Text] [Related]
7. Requirements within the Ebola Viral Glycoprotein for Tetherin Antagonism.
Vande Burgt NH; Kaletsky RL; Bates P
Viruses; 2015 Oct; 7(10):5587-602. PubMed ID: 26516900
[TBL] [Abstract][Full Text] [Related]
8. Release of Immunomodulatory Ebola Virus Glycoprotein-Containing Microvesicles Is Suppressed by Tetherin in a Species-Specific Manner.
Nehls J; Businger R; Hoffmann M; Brinkmann C; Fehrenbacher B; Schaller M; Maurer B; Schönfeld C; Kramer D; Hailfinger S; Pöhlmann S; Schindler M
Cell Rep; 2019 Feb; 26(7):1841-1853.e6. PubMed ID: 30759394
[TBL] [Abstract][Full Text] [Related]
9. Ebola Virus Requires Phosphatidylserine Scrambling Activity for Efficient Budding and Optimal Infectivity.
Acciani MD; Lay Mendoza MF; Havranek KE; Duncan AM; Iyer H; Linn OL; Brindley MA
J Virol; 2021 Sep; 95(20):e0116521. PubMed ID: 34319156
[TBL] [Abstract][Full Text] [Related]
10. Interferon-Induced HERC5 Inhibits Ebola Virus Particle Production and Is Antagonized by Ebola Glycoprotein.
Paparisto E; Hunt NR; Labach DS; Coleman MD; Di Gravio EJ; Dodge MJ; Friesen NJ; Côté M; Müller A; Hoenen T; Barr SD
Cells; 2021 Sep; 10(9):. PubMed ID: 34572049
[TBL] [Abstract][Full Text] [Related]
11. Cooperation of the Ebola Virus Proteins VP40 and GP
Rizk MG; Basler CF; Guatelli J
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878074
[TBL] [Abstract][Full Text] [Related]
12. Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.
Kaletsky RL; Francica JR; Agrawal-Gamse C; Bates P
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2886-91. PubMed ID: 19179289
[TBL] [Abstract][Full Text] [Related]
13. Mucin-Like Domain of Ebola Virus Glycoprotein Enhances Selective Oncolytic Actions against Brain Tumors.
Zhang X; Zhang T; Davis JN; Marzi A; Marchese AM; Robek MD; van den Pol AN
J Virol; 2020 Mar; 94(8):. PubMed ID: 32051271
[TBL] [Abstract][Full Text] [Related]
14. ALIX Rescues Budding of a Double PTAP/PPEY L-Domain Deletion Mutant of Ebola VP40: A Role for ALIX in Ebola Virus Egress.
Han Z; Madara JJ; Liu Y; Liu W; Ruthel G; Freedman BD; Harty RN
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S138-45. PubMed ID: 25786915
[TBL] [Abstract][Full Text] [Related]
15. Ebolavirus Replication and Tetherin/BST-2.
Yasuda J
Front Microbiol; 2012; 3():111. PubMed ID: 22485110
[TBL] [Abstract][Full Text] [Related]
16. Ebola virus requires a host scramblase for externalization of phosphatidylserine on the surface of viral particles.
Nanbo A; Maruyama J; Imai M; Ujie M; Fujioka Y; Nishide S; Takada A; Ohba Y; Kawaoka Y
PLoS Pathog; 2018 Jan; 14(1):e1006848. PubMed ID: 29338048
[TBL] [Abstract][Full Text] [Related]
17. TIM-1 serves as a receptor for Ebola virus in vivo, enhancing viremia and pathogenesis.
Brunton B; Rogers K; Phillips EK; Brouillette RB; Bouls R; Butler NS; Maury W
PLoS Negl Trop Dis; 2019 Jun; 13(6):e0006983. PubMed ID: 31242184
[TBL] [Abstract][Full Text] [Related]
18. A Polymorphism within the Internal Fusion Loop of the Ebola Virus Glycoprotein Modulates Host Cell Entry.
Hoffmann M; Crone L; Dietzel E; Paijo J; González-Hernández M; Nehlmeier I; Kalinke U; Becker S; Pöhlmann S
J Virol; 2017 May; 91(9):. PubMed ID: 28228590
[TBL] [Abstract][Full Text] [Related]
19. The glycoprotein of vesicular stomatitis virus promotes release of virus-like particles from tetherin-positive cells.
Brinkmann C; Hoffmann M; Lübke A; Nehlmeier I; Krämer-Kühl A; Winkler M; Pöhlmann S
PLoS One; 2017; 12(12):e0189073. PubMed ID: 29216247
[TBL] [Abstract][Full Text] [Related]
20. Enhanced
Chabot S; Gimie Y; Obeid K; Kim J; Meseda CA; Konduru K; Kaplan G; Sheng Fowler L; Weir JP; Peden K; Major ME
J Virol; 2022 Sep; 96(18):e0116621. PubMed ID: 36069549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
